Prostatic Acid Phosphatase Alters the RANKL/OPG System and Induces Osteoblastic Prostate Cancer Bone Metastases.

about

Cancer Metastases to Bone: Concepts, Mechanisms, and Interactions with Bone Osteoblasts.

P2860

Q55474543-16F4E42E-7221-48D6-B76C-56C73D2BD71D

P2860

Prostatic Acid Phosphatase Alters the RANKL/OPG System and Induces Osteoblastic Prostate Cancer Bone Metastases.

Item

http://www.wikidata.org/entity/Q38290477

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Prostatic Acid Phosphatase Alt ...... ostate Cancer Bone Metastases.

@en

type

Item

label

Prostatic Acid Phosphatase Alt ...... ostate Cancer Bone Metastases.

@en

prefLabel

Prostatic Acid Phosphatase Alt ...... ostate Cancer Bone Metastases.

@en

P1476

Prostatic Acid Phosphatase Alt ...... ostate Cancer Bone Metastases.

@en

P2093

Alan Huang

http://www.w3.org/2001/XMLSchema#string

Alexander Kirschenbaum

http://www.w3.org/2001/XMLSchema#string

Alice C Levine

http://www.w3.org/2001/XMLSchema#string

Elias M Gregoriades

http://www.w3.org/2001/XMLSchema#string

Kieley L O'Connor-Chapman

http://www.w3.org/2001/XMLSchema#string

Shen Yao

http://www.w3.org/2001/XMLSchema#string

Shoshana Yakar

http://www.w3.org/2001/XMLSchema#string

Sudeh Izadmehr

http://www.w3.org/2001/XMLSchema#string

P2860

Transmembrane prostatic acid phosphatase (TMPAP) interacts with snapin and deficient mice develop prostate adenocarcinoma

Reviving the acid phosphatase test for prostate cancer

Expression of RANKL/RANK/OPG in primary and metastatic human prostate cancer as markers of disease stage and functional regulation

Prostate cancer derived prostatic acid phosphatase promotes an osteoblastic response in the bone microenvironment.

Studies on prostatic cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate.

Bone metastasis in prostate cancer: emerging therapeutic strategies.

Transcriptional activation of the human prostatic acid phosphatase gene by NF-kappaB via a novel hexanucleotide-binding site.

Targeting IL-6 and RANKL signaling inhibits prostate cancer growth in bone.

Prostatic acid phosphatase is expressed in human prostate cancer bone metastases and promotes osteoblast differentiation.

RANKL acts directly on RANK-expressing prostate tumor cells and mediates migration and expression of tumor metastasis genes.

P304

4526-4533

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/EN.2016-1606

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

157

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27783536

http://www.w3.org/2001/XMLSchema#string

P932

5133341

http://www.w3.org/2001/XMLSchema#string

Prostatic Acid Phosphatase Alters the RANKL/OPG System and Induces Osteoblastic Prostate Cancer Bone Metastases.

about

P2860

P2860

Prostatic Acid Phosphatase Alters the RANKL/OPG System and Induces Osteoblastic Prostate Cancer Bone Metastases.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932